立体定向放射外科治疗卒中继发药物难治性三叉神经痛:系统综述与临床病例报告
本文报告一例82岁男性脑桥梗死继发三叉神经痛患者,经药物保守治疗失败后接受立体定向放射外科(SRS)治疗,并系统综述1976至2022年脑干卒中相关三叉神经痛病例。综述共纳入21篇病例报告、25例患者,仅3例接受SRS,其中2例在6个月和8个月随访时症状改善且无不良事件。作者认为SRS可考虑作为卒中相关三叉神经痛的安全有效治疗选择。
要点
- 82岁男性脑桥梗死继发三叉神经痛,药物保守治疗超过5年失败后接受SRS,边缘剂量60 Gy。
- 治疗后BNI评分立即降至0并维持3个月,复发后经奥卡西平控制,1年随访BNI评分为3。
- 系统综述纳入25例卒中继发三叉神经痛患者,仅3例接受SRS,其中2例随访6个月和8个月时症状改善。
核心结论
- 作者认为,本病例及文献综述显示SRS治疗具有持久且有效的效果,可考虑作为卒中相关三叉神经痛患者的安全有效治疗选择。
研究设计与样本
- 本文为系统综述及临床病例报告,按照PRISMA指南系统检索1976年至2022年所有脑干卒中相关三叉神经痛病例。
主要发现
- 本例患者为82岁男性,MRI显示脑桥病灶符合卒中,就诊时BNI评分为5。
- 患者接受单次SRS治疗,边缘剂量60 Gy,处方于80%等剂量线,治疗体积0.05 cm³。
- 治疗后即刻BNI评分为0,并维持0至3个月时出现复发,复发后接受奥卡西平治疗。
- 1年随访时,患者以较低剂量奥卡西平即获良好疼痛控制,无不良反应,BNI评分为3。
- 系统综述共纳入21篇病例报告、合计25例卒中继发三叉神经痛患者,其中仅3例接受SRS,2例分别在随访6个月和8个月时报告症状改善且无不良事件。
临床怎么用
- 作者认为SRS可考虑作为卒中相关三叉神经痛的安全有效治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Trigeminal neuralgia (TN) is a paroxysmal, unilateral, brief, shock-like pain in ≥1 divisions of the trigeminal nerve. It can result from multiple causes; however, TN secondary to stroke is very rare. METHODS: We present the case of TN secondary to pontine infarction treated with incremental doses of neuropathic pain medication for >5 years before conservative management failed. He was then treated with stereotactic radiosurgery (SRS). Additionally, we conducted a systematic review using standard PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines for all the cases of TN with brainstem stroke from 1976 to 2022. RESULTS: Our patient was an 82-year-old man. Magnetic resonance imaging demonstrated a pontine lesion consistent with stroke. The Barrow Neurological Institute (BNI) score at presentation was 5. He received a marginal dose of 60 Gy to the 80% isodose line in a single fraction to a volume of 0.05 cm3. The immediate post-treatment BNI score was 0 and remained at 0 for 3 months, when he experienced recurrence. The recurrence was treated with oxcarbazepine. His pain remained well controlled with a lower dose of oxcarbazepine, and he had no adverse effects at 1 year of follow-up with a BNI score of 3. The systemic review identified 21 case reports with a combined cohort of 25 patients with TN secondary to stroke. Only 3 patients were treated with SRS, 2 of whom reported symptom improvement at 6 months and 8 months of follow-up with no adverse events. CONCLUSIONS: Our case and literature review demonstrate durable and effective treatment with SRS, which can be considered a safe and effective treatment option for patients with stroke-associated TN.
引用
- Zamarud A, Park DJ, Ung TH, et al. Stereotactic Radiosurgery for Medically Refractory Trigeminal Neuralgia Secondary to Stroke: A Systematic Review and Clinical Case Presentation. World Neurosurg. 2023. PMID: 37640262. doi:10.1016/j.wneu.2023.08.092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。